IL1B and breast cancer: Interleukin-1B (IL-1B) is a pro-inflammatory cytokine whose expression in primary tumours has been identified as a potential biomarker for predicting breast cancer patients at increased risk for developing bone metastasis (Nutter et al. 2014).